664 the Neurokinin a/Nk2r Axis Controls IL-10 Levels to Inhibit Activation of Cutaneous MCs in Vitro and in Vivo

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.740
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Activation of Peroxisome Proliferator-Activated Receptor Does Not Inhibit IL-6 or TNF- Responses of Macrophages to Lipopolysaccharide in Vitro or in Vivo

Journal of Immunology
AllergyImmunology
2000English

Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in Vitro and in Vivo

Frontiers in Pharmacology
Pharmacology
2019English

Sialic Acid Glycoproteins Inhibit in Vitro and in Vivo Replication of Rotaviruses.

Journal of Clinical Investigation
Medicine
1987English

Serum Cytokine of Il-2, Il-10 and Il-12 Levels in Patients With Stomach Adenocarcinoma

Arquivos de Gastroenterologia
Gastroenterology
2018English

P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2018English

Circulating IL-10 Levels in Carotid Artery Disease

Serbian Journal of Experimental and Clinical Research
Medicine
2019English

652 Protection Strategies to Inhibit Blue Light Irradiation Effects In-Vitro and in Skin Ex-Vivo

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes

Clinical Biochemistry
MedicineClinical Biochemistry
2011English

Glycosphingolipids MediatePneumocystisCell Wall Β-Glucan Activation of the IL-23/IL-17 Axis in Human Dendritic Cells

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy